MedReleaf (TSE:LEAF) insider Ray Leach sold 41,500 shares of the company’s stock in a transaction on Friday, April 6th. The shares were sold at an average price of C$15.40, for a total value of C$639,100.00.
Ray Leach also recently made the following trade(s):
- On Wednesday, March 7th, Ray Leach sold 100,000 shares of MedReleaf stock. The shares were sold at an average price of C$19.75, for a total value of C$1,975,000.00.
- On Tuesday, February 27th, Ray Leach sold 19,600 shares of MedReleaf stock. The shares were sold at an average price of C$19.00, for a total value of C$372,400.00.
- On Thursday, March 1st, Ray Leach sold 77,800 shares of MedReleaf stock. The shares were sold at an average price of C$20.04, for a total value of C$1,559,112.00.
LEAF opened at C$16.80 on Thursday. MedReleaf has a 52 week low of C$6.81 and a 52 week high of C$31.25.
A number of analysts recently commented on the company. Canaccord Genuity increased their price objective on MedReleaf from C$21.50 to C$30.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Cowen increased their price objective on MedReleaf from C$20.00 to C$36.00 in a research note on Monday, January 8th.
ILLEGAL ACTIVITY NOTICE: “Ray Leach Sells 41,500 Shares of MedReleaf (LEAF) Stock” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/04/12/ray-leach-sells-41500-shares-of-medreleaf-leaf-stock.html.
MedReleaf Company Profile
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Receive News & Ratings for MedReleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf and related companies with MarketBeat.com's FREE daily email newsletter.